Table 1 Clinical characteristics of the participants.
Control (n = 5) | Obesity (n = 5) | T2DM (n = 5) | T1DM (n = 5) | P | |
|---|---|---|---|---|---|
Sex [fem], n (%) | 2 (40%) | 2 (40%) | 3 (60%) | 2 (40%) | 0.895† |
Age [months] | 166 (133, 183) | 159 (124, 188) | 174 (129, 202) | 158 (133, 210) | 0.915‡ |
ZS IMC (DE) | 0.21 (−0.05, 0.53) | 2.86 (2.63, 3.96) | 0.71 (−0.34, 2.55) | −0.46 (−1.07, 1.17) | <0.001‡ |
Evolution [months] | — | — | 28 (12, 56) | 30 (0, 60) | 0.882‡ |
Glucose [mg/dL] | 91 (81, 92) | 95 (90, 98) | 103 (96, 308) | 300 (185, 518) | 0.013‡ |
HbA1c [%] | 5.6 (5.2, 6.0) | 4.9 (4.6, 5.1) | 7.7 (5.3, 12.8) | 12.5 (10.8, 14.0) | 0.002‡ |
Toral cholesterol [mg/dL] | 92 (74, 140) | 151 (105, 184) | 169 (100, 312) | 178 (123, 212) | 0.044‡ |
HDL-C [mg/dL] | 43 (33, 57) | 33 (31, 40) | 50 (32, 68) | 41 (38, 48) | 0.072‡ |
Triglycerides (mg/dL) | 65 (52, 115) | 195 (120, 259) | 173 (50, 537) | 82 (48, 400) | 0.066‡ |
Uric acid (mg/dL) | 6.4 (3.9, 6.7) | 5.5 (3.5, 6.7) | 4.3 (3.6, 4.9) | 3.6 (3.1, 9.3) | 0.463‡ |
Insulin Tx. [Sí], n (%) | — | — | 0 (0%) | 6 (100%) | 0.002† |
Insulin dosage | — | — | — | 0.81 (0.54, 1.14) | — |
